Acquired resistance to cetuximab is associated with the overexpression of Ras family members and the loss of radiosensitization in head and neck cancer cells
Conclusion: Targeting Ras and PI3K activity improves the outcome of irradiation in cetuximab-resistant HNSCC cell lines in vitro.
Source: Radiotherapy and Oncology - Category: Radiology Authors: Mohammad Saki, Mahmoud Toulany, H. Peter Rodemann Tags: Original Articles Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Erbitux | HNSCC | Radiation Therapy | Radiology | Skin Cancer | Squamous Cell Carcinoma | Study